| | | | | | | | | | |
|
|
|
| Dockets Entered
On November 4, 2003
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1995N-0304
|
| Ephedrine Alkaloids: Reports of Adverse Events; Availability
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| 1998D-1146
|
| Microbial effects of antimicrobial new animal drugs/human sa
|
|
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
|
|
| 1998P-0610
|
| Convert Allegra/Allegra-D,Claritin/Claritin-D,Zyrtec to OTC
|
|
|
|
|
| 1999N-4282
|
| Biotechnology in the Year 2000 and Beyond; Public Meetings
|
|
|
|
|
| 1999P-1340
|
| Declared Eternity eau de Parfum Misbranded
|
|
|
|
|
| 1999P-2630
|
| Establish a Daily Value for "added sugars"
|
|
|
|
|
| 2000P-0685
|
| Revise of Yogurt Standards
|
|
|
|
|
| 2000P-1211
|
| Establish Mandatory Pre-Market Safety Testing for GE Foods
|
|
|
|
|
| 2002D-0325
|
| Polyvinychloride using Plasticier di-(2-ethyhexyl)phthalate
|
|
|
|
|
| 2002D-0525
|
| Medical Devices; Chemical Indicators Premarket Notification
|
|
|
|
|
| 2003D-0165
|
| Current Good Manufacturing Practices for Medical Gases
|
|
|
|
|
| 2003D-0497
|
| Guidance for Industry on Pharmacogenomic Data Submissions
|
|
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
|
|
| 2003N-0400
|
| Control of Communicable Diseases; Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals
|
|
|
|
|
| 2003P-0274
|
| In re Tier 1 initial Approval Program
|
|
|
|
|
| 2003Q-0401
|
| Qualified Health Claim (QHC) Omega-3 Fatty Acids and Coronoary Heart Disease Health Claim
|
|
|
|
|
| 2003V-0510
|
| Laser Light Show
|
|
|
|
|
| 1995N-0304
|
| Ephedrine Alkaloids: Reports of Adverse Events; Availability
|
|
|
|
|
| EMC 932
|
| Linda Tursi
|
| Vol #:
|
| 375
|
|
|
|
|
| EMC 933
|
| Nicole Gostkowski
|
| Vol #:
|
| 375
|
|
|
|
|
| EMC 934
|
| Russ O'Connell
|
| Vol #:
|
| 375
|
|
|
|
|
| EMC 935
|
| No signature
|
| Vol #:
|
| 375
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| LET
11438
|
| Natural Organics Inc.
|
| Vol #:
|
| 88
|
|
|
|
|
| LET
11439
|
| Natural Organics Inc.
|
| Vol #:
|
| 88
|
|
|
|
|
| LET
11440
|
| Natural Organics Inc.
|
| Vol #:
|
| 88
|
|
|
|
|
| LET
11441
|
| Natural Organics Inc.
|
| Vol #:
|
| 88
|
|
|
|
|
| LET
11442
|
| PhytoPharmica Nautral Medicines
|
| Vol #:
|
| 88
|
|
|
|
|
| LET
11443
|
| PhytoPharmica Natural Medicines
|
| Vol #:
|
| 88
|
|
|
|
|
| LET
11444
|
| PhytoPharmica Natural Medicines
|
| Vol #:
|
| 88
|
|
|
|
|
| LET
11445
|
| PhytoPharmica Natural Medicines
|
| Vol #:
|
| 88
|
|
|
|
|
| LET
11446
|
| PhytoPharmica Natural Medicines
|
| Vol #:
|
| 88
|
|
|
|
|
| LET
11447
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 88
|
|
| | | | | | | | |
|
|
|
|
| LET
11448
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 88
|
|
|
|
|
| LET
11449
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 88
|
|
|
|
|
| LET
11450
|
| Enzymatic Therapy Nautral Medicines
|
| Vol #:
|
| 88
|
|
|
|
|
| LET
11451
|
| Michael's Naturopathic Programs
|
| Vol #:
|
| 88
|
|
|
|
|
| LET
11452
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 88
|
|
|
|
|
| LET
11453
|
| Premier Labs, Inc.
|
| Vol #:
|
| 88
|
|
|
|
|
| LET
11454
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 88
|
|
|
|
|
| LET
11455
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 88
|
|
|
|
|
| LET
11456
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 88
|
|
|
|
|
| LET
11457
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 88
|
|
|
|
|
| LET
11458
|
| Natrol, Inc.
|
| Vol #:
|
| 88
|
|
|
|
|
| LET
11459
|
| Prolab Nutrition, Inc.
|
| Vol #:
|
| 88
|
|
|
|
|
| LET
11460
|
| Maitake Products, Inc.
|
| Vol #:
|
| 88
|
|
|
|
|
| LET
11461
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 88
|
|
|
|
|
| LET
11462
|
| Natural Source International, Ltd.
|
| Vol #:
|
| 88
|
|
|
|
|
| LET
11463
|
| Nature's Life
|
| Vol #:
|
| 89
|
|
|
|
|
| LET
11464
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 89
|
|
|
|
|
| 1998D-1146
|
| Microbial effects of antimicrobial new animal drugs/human sa
|
|
|
|
|
| EMC 701
|
| Patrick Sweeney
|
| Vol #:
|
| 19
|
|
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
|
|
| EMC 3895
|
| Paula Peters
|
| Vol #:
|
| 304
|
|
|
|
|
| EMC 3896
|
| Sister Ann Kasparek
|
| Vol #:
|
| 304
|
|
|
|
|
| EMC 3897
|
| Kathleen Poli
|
| Vol #:
|
| 304
|
|
|
|
|
| EMC 3898
|
| Heather Kuberski
|
| Vol #:
|
| 304
|
|
|
|
|
| EMC 3899
|
| Natalie Helms
|
| Vol #:
|
| 304
|
|
|
|
|
| EMC 3900
|
| Kerry J. Schmitt
|
| Vol #:
|
| 304
|
|
|
|
|
| EMC 3901
|
| Andrew M.J. Karpouzes
|
| Vol #:
|
| 304
|
|
|
|
|
| EMC 3902
|
| Cynthia O'toole
|
| Vol #:
|
| 304
|
|
|
|
|
| EMC 3903
|
| Ruth Rasmussen
|
| Vol #:
|
| 304
|
|
|
|
|
| EMC 3904
|
| Mr & Mrs William Cover
|
| Vol #:
|
| 304
|
|
|
|
|
| EMC 3905
|
| Debbie Spafford
|
| Vol #:
|
| 304
|
|
|
|
|
| EMC 3906
|
| Rebecca Morris
|
| Vol #:
|
| 304
|
|
|
|
|
| EMC 3907
|
| Eric Erickson
|
| Vol #:
|
| 304
|
|
|
|
|
| EMC 3908
|
| Tama Herman
|
| Vol #:
|
| 304
|
|
|
|
|
| EMC 3909
|
| Pam Stiltjes
|
| Vol #:
|
| 304
|
|
| | | | | | | | |
|
|
|
|
| EMC 135
|
| Karen L. Martellaro
|
| Vol #:
|
| 3
|
|
|
|
|
| 2002D-0525
|
| Medical Devices; Chemical Indicators Premarket Notification
|
|
|
|
|
| EMC 2
|
| Cindi Wilson
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003D-0165
|
| Current Good Manufacturing Practices for Medical Gases
|
|
|
|
|
| EMC
1
|
| Michigan Home Health Assn (MHHA)
|
| Vol #:
|
| 2
|
|
|
|
|
| EMC
2
|
| Airgas, Inc.
|
| Vol #:
|
| 2
|
|
|
|
|
| EMC
3
|
| Lincare
|
| Vol #:
|
| 2
|
|
|
|
|
| 2003D-0497
|
| Guidance for Industry on Pharmacogenomic Data Submissions
|
|
|
|
|
| GDL
1
|
| Guidance
|
| Vol #:
|
| 1
|
|
|
|
|
| NAD
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
|
|
| EMC 98
|
| No signature
|
| Vol #:
|
| 3
|
|
|
|
|
| EMC 99
|
| Becky Bowers Greene
|
| Vol #:
|
| 3
|
|
|
|
|
| EMC 100
|
| Lauren Ayers
|
| Vol #:
|
| 3
|
|
|
|
|
| EMC 101
|
| Lisa Edgar
|
| Vol #:
|
| 3
|
|
|
|
|
| EMC 102
|
| Lisa Edgar
|
| Vol #:
|
| 3
|
|
|
|
|
| 2003N-0400
|
| Control of Communicable Diseases; Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals
|
|
|
|
|
| BKG 1
|
| Background Material
|
| Vol #:
|
| 1
|
|
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003P-0274
|
| In re Tier 1 initial Approval Program
|
|
|
|
|
| EMC 7
|
| Patricia Haas
|
| Vol #:
|
| 1
|
|
|
|
|
| EMC 8
|
| Michael Post
|
| Vol #:
|
| 1
|
|
|
|
|
| EMC 9
|
| Brian Mark Gray
|
| Vol #:
|
| 1
|
|
|
|
|
| EMC 10
|
| Vince Roscelli
|
| Vol #:
|
| 1
|
|
|
|
|
| EMC 11
|
| Theodore J. Cohen
|
| Vol #:
|
| 1
|
|
|
|
|
| EMC 12
|
| LeRoy E. Day
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003Q-0401
|
| Qualified Health Claim (QHC) Omega-3 Fatty Acids and Coronoary Heart Disease Health Claim
|
|
|
|
|
| EMC
1
|
| Martek Biosciences Corporation
|
| Vol #:
|
| 2
|
|
|
|
|
| 2003V-0510
|
| Laser Light Show
|
|
|
|
|
| VAR
1
|
| InterVision
|
| Vol #:
|
| 1
|
|
Page created November 5, 2003 jb
